MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1355.40%
Quick Ratio
1355.40%
Cash Ratio
1333.42%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Other noncurrent assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accumulated other comprehensive ...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
41,233,428
46,466,202
14,599,347
13,718,052
Prepaid expenses and other current assets
679,686
779,238
961,899
225,936
Total current assets
41,913,114
47,245,440
15,561,246
13,943,988
Property and equipment, net
64,033
54,379
59,807
65,236
Restricted cash
41,615
41,406
41,186
40,930
Other noncurrent assets
271,162
271,162
271,162
271,162
Total assets
42,289,924
47,612,387
15,933,401
14,321,316
Accounts payable
935,139
2,940,756
713,668
641,322
Accrued expenses
2,157,163
2,355,890
2,050,690
2,039,785
Total current liabilities
3,092,302
5,296,646
2,764,358
2,681,107
Series a convertible preferred stock, 0.001 par value, 40,000,000 shares authorized 31,194 shares issued and outstanding at june 30, 2026 and december 31, 2025
727,361
727,361
727,361
727,361
Common stock, 0.001 par value, 400,000,000 shares authorized, 12,391,136 and 8,192,538 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
12,391
11,983
8,192
5,979
Additional paid-in capital
389,596,149
389,631,454
356,709,645
352,722,214
Subscription receivable
-
499,999
-
-
Accumulated other comprehensive loss
-10,617,617
-10,625,700
-10,634,714
-10,629,534
Accumulated deficit
-340,520,662
-336,929,358
-333,641,441
-331,185,811
Total stockholders' equity
38,470,261
41,588,380
12,441,682
10,912,848
Total liabilities and stockholders' equity
42,289,924
47,612,387
15,933,401
14,321,316
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$41,233,428 (149.41%↑ Y/Y)Prepaid expenses andother current assets$679,686 (72.07%↑ Y/Y)Total current assets$41,913,114 (147.61%↑ Y/Y)Other noncurrentassets$271,162 (0.00%↑ Y/Y)Property and equipment,net$64,033 (-9.39%↓ Y/Y)Restricted cash$41,615 (2.32%↑ Y/Y)Total assets$42,289,924 (144.31%↑ Y/Y)Total liabilities andstockholders' equity$42,289,924 (144.31%↑ Y/Y)Total stockholders'equity$38,470,261 (186.78%↑ Y/Y)Total currentliabilities$3,092,302 (-2.38%↓ Y/Y)Series a convertiblepreferred stock, 0.001 par...$727,361 (0.00%↑ Y/Y)Accumulated deficit-$340,520,662 (-3.75%↓ Y/Y)Accumulated othercomprehensive loss-$10,617,617 (0.10%↑ Y/Y)Additional paid-in capital$389,596,149 (10.60%↑ Y/Y)Accrued expenses$2,157,163 (9.40%↑ Y/Y)Accounts payable$935,139 (-21.80%↓ Y/Y)Common stock, 0.001 parvalue, 400,000,000...$12,391 (115.42%↑ Y/Y)

Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics, Inc. (APRE)